Amid the COVID-19 crisis, the global market for ultraviolet germicidal irradiation, estimated at $454.4 million in the year 2022, is projected to reach a revised size of $682.9 million by 2026, growing at a compounded annual growth rate (CAGR) of 12 percent over the analysis period.
The COVID-19 crisis is fostering the ultraviolet (UV) disinfection equipment market by creating a pressing need to stop the spread of the virus. UV disinfection is a chemical-free process that exposes pathogens in a gaseous or liquid medium or on surfaces to UV irradiation for deactivating the DNA to hinder reproduction of the pathogen.
Related Content: UV Disinfection Technology Gets Boost
Several studies have indicated that the use of a specific wavelength of UV light can kill over 99.9 percent of COVID-19 viruses present on surfaces and in airborne droplets. UVC germicidal irradiation also offers effective physical disinfection and holds optimal germicidal effect and does not leave residues.
These benefits have resulted in strong demand and adoption of UV disinfection equipment across healthcare settings, offices and other workspaces. The COVID-19 outbreak provided a significant impetus to global shipment of UV disinfection equipment, a trend that is unlikely to abate soon.
After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the surface disinfectant segment is readjusted to a revised 10.3 percent CAGR for the next seven-year period. This segment accounts for a 14.2 percent share of the global ultraviolet germicidal irradiation market.
Preparing Healthcare Facilities for Wildfire Air Quality Events
UW Health Set to Open Expansion at East Madison Hospital
Central Ohio Primary Care Physicians Falls Victim to Cyberattack
The Role of Biophilic Design in Healthcare Facilities
TriStar Centennial Medical Center Invests $90M in Women, Children's Hospital Expansions